American Thoracic Society (ATS)

“For My Lung Health” Campaign Promotes Lung Health Education in Underserved Black and Latino Communities

Two global leaders in lung health care, the American Thoracic Society and the American College of Chest Physicians, launch website and media campaign directed at providing credible resources for patients and families disproportionally affected by COVID-19.

Newswise — June 29, 2020 -- This month the American Thoracic Society (ATS) and the American College of Chest Physicians (CHEST) launched For My Lung Health, a patient-education website and media campaign. Using public service announcements and an education-based website, For My Lung Health focuses on empowering people from underserved communities who live with chronic lung disease.

As a joint effort between two leading global authorities in lung health, For My Lung Health is aimed at reducing the disparity in access to vital resources. Making lung health a priority can be challenging for many patients, especially for those who face inequities in accessing health care. Amidst the novel coronavirus (COVID-19) pandemic it is important to take control of one’s lung health. Ensuring access to credible information developed and endorsed by respiratory medical professionals and other advocacy-based organizations representing patients across the chronic lung condition spectrum is one way to enable individuals to make knowledgeable choices.

“It gives me peace of mind knowing that this campaign is alerting the community to how COVID-19 affects people like me who are at high risk for pulmonary seizures,” said Carmen Camacho of the Hermansky-Pudlak Syndrome Network, ATS Public Advisory Roundtable (PAR), a partnership of organizations representing patients with lung disease.

Ensuring that information and access to resources reach the people most affected by COVID-19, who also have chronic lung disease, is a top priority for ATS and CHEST. Statistically, COVID-19 disproportionately affects people of color, including Black and Latino communities.

The For My Lung Health online media campaign targets locations showing the highest pandemic impact on underserved populations. The public service message, produced in both English and Spanish, offers supportive tips and directs viewers to additional online resources. The media campaign will last throughout the summer and has a goal of reaching more than a million viewers. In the first nine days after the launch, more than 355,000 complete video views were tracked on YouTube and there have been more than 1,600 unique visits to the website.

The For My Lung Health website provides disease-specific information, in video and written formats, on many chronic lung diseases such as asthma, chronic obstructive pulmonary disease (COPD), idiopathic pulmonary fibrosis (IPF) and COVID-19. The educational material was developed by ATS and CHEST’s broad network of providers, clinical education experts, and partners. The website will continue to be available and updated as need.

“Whether it is dealing with the daily effects of a chronic lung disease or the impact of a pandemic virus that targets the lungs, ensuring that patients and their families have the information they need to make crucial decisions about their health must be a priority for all healthcare providers. We have resources that can provide credible, lifesaving information for some patients, especially those who are isolated or do not have readily available access to health care. This campaign helps us get that information to the people who need it most,” said Stephanie M. Levine, MD, FCCP, and President of CHEST.

“Two reasons for the racial/ethnic disparities in the ongoing pandemic are lack of information about the health risks of COVID-19 and limited access or use of healthcare services. The For My Lung Health campaign provides good information while encouraging patients to seek proper health care. Despite the spread of COVID-19, patients should not dismiss early symptoms out of fear of contracting the virus,” said ATS President Juan C. Celedón, MD, DrPH, ATSF. “Telehealth options, allowing video or phone chats with providers, are available to patients during the pandemic. Talk to your provider, particularly if you have an underlying lung condition.”

This project was generously funded through an educational grant by GlaxoSmithKline and a donation from Boehringer Ingelheim, both as part of the ATS COVID-19 Crisis Fund.

 

Share via Twitter:
The #ForMyLungHealth campaign advocates for lung health care in #Black and #Latino communities through education. #lunghealth #covid19 @atscommunity @accpchest

 

###

 

About the American Thoracic Society

Founded in 1905, the American Thoracic Society is a leading global medical association dedicated to advancing pulmonary, critical care, and sleep medicine. The Society’s more than 16,000 members prevent and fight respiratory disease around the globe through research, education, patient care, and advocacy. The ATS publishes four journals, the American Journal of Respiratory and Critical Care Medicine, the American Journal of Respiratory Cell and Molecular Biology, the Annals of the American Thoracic Society, and ATS Scholar.

 

About the American College of Chest Physicians

The American College of Chest Physicians® (CHEST) is a global leader in the prevention, diagnosis and treatment of chest diseases. Its mission is to champion advanced clinical practice, education communication and research in chest medicine. It serves as an essential connection to clinical knowledge and resources for its 19,000+ members from around the world who provide patient care in pulmonary, critical care and sleep medicine. For information about the American College of Chest Physicians, and its flagship journal CHEST®, visit chestnet.org.




Filters close

Showing results

110 of 3755
Newswise: New Landmark Study at UM School of Medicine Finds Aspirin Use Reduces Risk of Death in Hospitalized COVID-19 Patients
Released: 22-Oct-2020 2:40 PM EDT
New Landmark Study at UM School of Medicine Finds Aspirin Use Reduces Risk of Death in Hospitalized COVID-19 Patients
University of Maryland Medical Center

Hospitalized COVID-19 patients who were taking a daily low-dose aspirin to protect against cardiovascular disease had a significantly lower risk of complications and death compared to those who were not taking aspirin, according to a new study led by researchers at the University of Maryland School of Medicine (UMSOM).

Released: 22-Oct-2020 2:25 PM EDT
Tocilizumab doesn't ease symptoms or prevent death in moderately ill COVID-19 inpatients
Massachusetts General Hospital

The drug tocilizumab (Actemra) does not reduce the need for breathing assistance with mechanical ventilation or prevent death in moderately ill hospitalized patients with COVID-19, according to a new study led by researchers at Massachusetts General Hospital (MGH).

Released: 22-Oct-2020 2:10 PM EDT
New York Gov. Andrew Cuomo said that nursing homes "never needed" to accept patients who tested positive for COVID-19, but they did accept them
Newswise

According to a report from the New York State Department of Health, "6,326 COVID-positive residents were admitted to [nursing home] facilities" following Cuomo's mandate that nursing homes accept the readmission of COVID-positive patients from hospitals. Therefore we rate his claim as false.

Released: 22-Oct-2020 2:10 PM EDT
U of M trial shows hydroxychloroquine does not prevent COVID-19 in health care workers
University of Minnesota

University of Minnesota Medical School physician researchers studied hydroxychloroquine as a treatment to prevent COVID-19 for those with high-risk for exposure to the virus - health care workers.

Newswise: UNLV Physician: Why COVID-19 Makes Flu Shots More Important Than Ever
Released: 22-Oct-2020 1:50 PM EDT
UNLV Physician: Why COVID-19 Makes Flu Shots More Important Than Ever
University of Nevada, Las Vegas (UNLV)

As the race for a COVID-19 vaccine intensifies, health care officials are reminding the public not to forget another important vaccine this fall: the flu shot. Flu season in the U.S. technically began in September, with illnesses expected to peak in December and February, according to the Centers for Disease Control (CDC). Less than half of Americans received a flu vaccine during the 2019-2020 flu season, and a staggering 405,000 hospitalizations and 22,000 deaths were attributed to influenza.

Newswise: 246630_web.jpg
Released: 22-Oct-2020 1:45 PM EDT
Immune response the probable underlying cause of neural damage in COVID-19
University of Gothenburg

It is probably the immune response to, rather than the virus in itself, that causes sudden confusion and other symptoms from the nervous system in some patients with COVID-19. This is shown by a study of cases involving six Swedish patients, now published in the journal Neurology.

Released: 22-Oct-2020 1:35 PM EDT
COVID-19 study: Meaning in life and self-control protect against stress
University of Innsbruck

Numerous studies over the last few weeks have pointed out that the effects of the Corona pandemic on people's mental health can be enormous and affect large parts of the population.

Newswise: Hackensack Meridian CDI, University of Michigan Demonstrate Better, Faster COVID-19 Antibody Testing
Released: 22-Oct-2020 1:30 PM EDT
Hackensack Meridian CDI, University of Michigan Demonstrate Better, Faster COVID-19 Antibody Testing
Hackensack Meridian Health

A new portable “lab on a chip,” developed by the U-M scientists and demonstrated with help of the CDI, can identify the presence of COVID-19 antibodies in blood donors with greater speed and efficiency

Released: 22-Oct-2020 1:10 PM EDT
Relieving the cost of COVID-19 by Parrondo's paradox
Singapore University of Technology and Design

The outbreak of coronavirus disease 2019 (COVID-19) has spread rapidly across the globe at an alarming pace, causing considerable anxiety and fear among the general public.

Newswise: COVID-19 infection may be part of a ‘perfect storm’ for Parkinson’s disease
Released: 22-Oct-2020 1:00 PM EDT
COVID-19 infection may be part of a ‘perfect storm’ for Parkinson’s disease
Van Andel Institute

GRAND RAPIDS, Mich. (Oct. 22, 2020) — Can COVID-19 infection increase the risk of developing Parkinson’s disease?


Showing results

110 of 3755

close
0.93869